Literature DB >> 10461890

Wnt signaling induces GLT-1 expression in rat C6 glioma cells.

T P Palos1, S Zheng, B D Howard.   

Abstract

The regulation of glial and neuronal Na+-dependent glutamate/aspartate transporters is of interest because abnormal glutamate transport may be responsible for certain neurological diseases. Because expression of the Wnt-1 protooncogene results in induction of the glial-type glutamate transporter GLAST in PC12 neuron-like cells, we have evaluated the effect of Wnt-1-induced signaling on glutamate transporter expression in rat C6 glioma cells. C6 cells are known normally to express EAAC1, a neuronal glutamate transporter, but not the GLAST or the GLT-1 glutamate transporter. C6 cells that ectopically expressed Wnt-1 contained a GLT-1 RNA species similar in size (>10 kb) to the GLT-1 transcript present in rat brain, and they also contained a previously unreported 3.3-kb GLT-1 RNA species. Both GLT-1 RNAs contain large parts of the coding region. However, the 3.3-kb GLT-1 species contains at least one small deletion within the coding region. The Wnt-1-expressing C6 cells contained little, if any, GLT-1 protein as determined by immunological techniques. We suggest that one or both of the GLT-1 RNA species induced by Wnt-1 either fail to be translated or yield abnormal translation products that are quickly degraded. Wnt-1-expressing C6 cells may thus represent a novel in vitro system for studying GLT-1 transporter expression at the transcriptional and/or posttranscriptional levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461890     DOI: 10.1046/j.1471-4159.1999.0731012.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

2.  miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Authors:  Kun Wang; Xuan Wang; Jian Zou; Anling Zhang; Yingfeng Wan; Peiyu Pu; Zhengfei Song; Cong Qian; Yili Chen; Shuxu Yang; Yirong Wang
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

3.  Epigenetic regulation of wnt pathway antagonists in human glioblastoma multiforme.

Authors:  Greg Foltz; Jae-Geun Yoon; Hwahyung Lee; Li Ma; Qiang Tian; Leroy Hood; Anup Madan
Journal:  Genes Cancer       Date:  2010-01

4.  Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.

Authors:  Ilya V Ulasov; Suvobroto Nandi; Mahua Dey; Adam M Sonabend; Maciej S Lesniak
Journal:  Mol Med       Date:  2010-10-15       Impact factor: 6.354

Review 5.  The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects.

Authors:  Yoshikatsu Kanai; Matthias A Hediger
Journal:  Pflugers Arch       Date:  2003-10-07       Impact factor: 3.657

6.  Cellular senescence induced by prolonged subculture adversely affects glutamate uptake in C6 lineage.

Authors:  Mery Stéfani Leivas Pereira; Kamila Zenki; Marcela Mendonça Cavalheiro; Chairini Cássia Thomé; Eduardo Cremonese Filippi-Chiela; Guido Lenz; Diogo Onofre Gomes de Souza; Diogo Losch de Oliveira
Journal:  Neurochem Res       Date:  2014-04-05       Impact factor: 3.996

7.  In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.

Authors:  Jason K Sa; Yeup Yoon; Misuk Kim; Yeonghwan Kim; Hee Jin Cho; Jin-Ku Lee; Gi-Soo Kim; Suji Han; Woon Jin Kim; Yong Jae Shin; Kyeung Min Joo; Patrick J Paddison; Tohru Ishitani; Jeongwu Lee; Do-Hyun Nam
Journal:  Oncotarget       Date:  2015-08-21

Review 8.  Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Front Physiol       Date:  2017-05-30       Impact factor: 4.566

Review 9.  Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson's Disease.

Authors:  Xiang Li; Wenjun Wang; Jianghong Yan; Fancai Zeng
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

10.  Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease.

Authors:  Lei Wei; Chuan Chen; Li Ding; Mingshu Mo; Jing Zou; Zhenze Lu; Haiyan Li; Haotian Wu; Yongqiang Dai; Pingyi Xu; Zhengqi Lu
Journal:  Neural Plast       Date:  2019-09-09       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.